Catalog No.
RVV25606
Species reactivity
Norwalk virus (strain GI/Human/United States/Norwalk/1968)(Hu/NV/NV/1968/US)
Host species
Human
Isotype
VHH-hFc
Clonality
Monoclonal
Target
Capsid protein VP1, CP, p59, Soluble capsid protein, Protein 30k, p30, ORF2
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
Q83884
Applications
ELISA
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Clone ID
Nano-7
An oral norovirus vaccine tablet was safe and elicited mucosal immunity in older adults in a phase 1b clinical trial., PMID:40043138
Broadly neutralizing antibodies targeting pandemic GII.4 variants or seven GII genotypes of human norovirus., PMID:40043137
Vaccinia Virus Vector Bivalent Norovirus Vaccine., PMID:40006992
Effect of trypsin digestion on the integrity and antigenic epitopes of GII.6 norovirus virus-like particles., PMID:39762616
Preliminary establishment and evaluation of a rapid detection method for GII human norovirus based on time-resolved fluorescence chromatography., PMID:39744883
Two Monoclonal Antibodies Targeting Distinct Subdomains of Human Norovirus P Protein., PMID:39463379
Patterns of the within-host evolution of human norovirus in immunocompromised individuals and implications for treatment., PMID:39396425
Development of genogroup-specific ELISAs based on the VP1 protein to detect antibodies to GIV and GVI feline norovirus., PMID:39292300
Replication-deficient Sendai virus expressing human norovirus capsid protein elicits robust NoV-specific antibody and T-cell responses in mice., PMID:39236991
A quadrivalent norovirus vaccine based on a chimpanzee adenovirus vector induces potent immunity in mice., PMID:38997087
Identification of a norovirus GII-specific antigenic epitope., PMID:38819530
Structural analyses of the GI.4 norovirus by cryo-electron microscopy and X-ray crystallography revealing binding sites for human monoclonal antibodies., PMID:38593321
The reversible activation of norovirus by metal ions., PMID:38236007
SpyTag/SpyCatcher display of influenza M2e peptide on norovirus-like particle provides stronger immunization than direct genetic fusion., PMID:37424789
Identification of a GII.6 norovirus blockade antibody epitope., PMID:37392840
Linear epitopes on the capsid protein of norovirus commonly elicit high antibody response among past-infected individuals., PMID:37280660
High yield production of norovirus GII.4 virus-like particles using silkworm pupae and evaluation of their protective immunogenicity., PMID:36528444
Generation of Recombinant Rotaviruses Expressing Human Norovirus Capsid Proteins., PMID:36314817
Distinct dissociation rates of murine and human norovirus P-domain dimers suggest a role of dimer stability in virus-host interactions., PMID:35680964
Recombinant norovirus capsid protein VP1 (GII.4) expressed in H5 insect cells exhibits post-translational modifications with potential impact on lectin activity and vaccine design., PMID:35312780
Assignment of Ala, Ile, LeuproS, Met, and ValproS methyl groups of the protruding domain of murine norovirus capsid protein VP1 using methyl-methyl NOEs, site directed mutagenesis, and pseudocontact shifts., PMID:35050443
Antigenicity and immunogenicity of HA2 and M2e influenza virus antigens conjugated to norovirus-like, VP1 capsid-based particles by the SpyTag/SpyCatcher technology., PMID:34894525
Structural Studies on the Shapeshifting Murine Norovirus., PMID:34834968
Identification of Human Norovirus GII.3 Blockade Antibody Epitopes., PMID:34696487
Receptor profile and immunogenicity of the non-epidemic norovirus GII.8 variant., PMID:34662679
Identification of a blockade epitope of human norovirus GII.17., PMID:33929932
Antigenic cartography reveals complexities of genetic determinants that lead to antigenic differences among pandemic GII.4 noroviruses., PMID:33836574
RNA-assisted self-assembly of monomeric antigens into virus-like particles as a recombinant vaccine platform., PMID:33465537
Broad-range and effective detection of human noroviruses by colloidal gold immunochromatographic assay based on the shell domain of the major capsid protein., PMID:33430771
Structural heterogeneity of a human norovirus vaccine candidate., PMID:33202318
High-Resolution Mapping of Human Norovirus Antigens via Genomic Phage Display Library Selections and Deep Sequencing., PMID:33055250
A photoelectrochemical biosensor for rapid and ultrasensitive norovirus detection., PMID:32645567
The Dynamic Life of Virus Capsids., PMID:32516952
Production and characterization of monoclonal antibodies against GII.6 norovirus virus-like particles., PMID:32109570
Immunogenicity and protective potency of Norovirus GII.17 virus-like particle-based vaccine., PMID:32088791
Genomic and biological characterization of a pandemic norovirus variant GII.4 Sydney 2012., PMID:31912284
Population Genomics of GII.4 Noroviruses Reveal Complex Diversification and New Antigenic Sites Involved in the Emergence of Pandemic Strains., PMID:31551337
Efficient Production of Human Norovirus-Specific IgY in Egg Yolks by Vaccination of Hens with a Recombinant Vesicular Stomatitis Virus Expressing VP1 Protein., PMID:31100802
The Antigenic Topology of Norovirus as Defined by B and T Cell Epitope Mapping: Implications for Universal Vaccines and Therapeutics., PMID:31083353
The Dynamic Capsid Structures of the Noroviruses., PMID:30857192
Linear epitope binding antibodies against GII.3 Norovirus exhibit no histo-blood group antigens (HBGAs) blocking effects., PMID:30725444
Structural basis for murine norovirus engagement of bile acids and the CD300lf receptor., PMID:30194229
Characterization of a Norovirus-specific monoclonal antibody that exhibits wide spectrum binding activities., PMID:29236287
Comprehensive characterization of a major capsid protein derived from a documented GII.6 norovirus strain., PMID:28866835
A Luciferase Immunoprecipitation System (LIPS) assay for profiling human norovirus antibodies., PMID:28673856
Expression and characterization of the major capsid protein derived from a GII.6 norovirus strain isolated in China., PMID:28219831
Norovirus-Specific Memory T Cell Responses in Adult Human Donors., PMID:27752254
Type-specific and cross-reactive antibodies and T cell responses in norovirus VLP immunized mice are targeted both to conserved and variable domains of capsid VP1 protein., PMID:27573255
Chimeric VLPs with GII.3 P2 domain in a backbone of GII.4 VP1 confers novel HBGA binding ability., PMID:27521750
Norovirus (NoV) specific protective immune responses induced by recombinant P dimer vaccine are enhanced by the mucosal adjuvant FlaB., PMID:27184355
For research use only. Not for human or drug use.
